: Daily maintenance with inhaled corticosteroids (ICS) —the standard treatment for asthma—may reduce the body's inflammatory response to the virus, potentially preventing the "cytokine storms" that lead to severe illness. A Note of Caution: Control is Key
In the early days of the pandemic, fear was the constant companion for those with respiratory conditions. For individuals with asthma, the logic seemed simple and terrifying: a virus that attacks the lungs would surely be devastating for those whose lungs were already compromised. Asthma May Not Boost Odds of Severe COVID-19
For most, the message is clear: staying consistent with daily medications and keeping asthma well-controlled provides a robust layer of protection, allowing many to "breathe easier" despite the ongoing presence of the virus. For most, the message is clear: staying consistent
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more AI responses may include mistakes
The story isn't the same for everyone. While asthma in general may not boost the odds of severe outcomes, remains a concern. A large-scale Swedish study published in February 2026 found that patients with very poor symptom control or frequent flare-ups still faced a higher risk of hospitalization if they contracted the virus.
: The SARS-CoV-2 virus enters cells via a receptor called ACE2 . In many people with allergic asthma, the expression of this receptor is naturally lower, giving the virus fewer "doors" to enter through.
However, as years of data have poured in, a surprising and reassuring story has emerged. Recent studies, including a major scoping review published in , indicate that asthma is not an independent risk factor for severe COVID-19 illness. The Protective Paradox